Candriam Luxembourg S.C.A. »

Stantec shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Stantec (STN) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Stantec

Tip: Access up to 7 years of quarterly data

All positions including Stantec held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stantec by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 37k 80.68
2022-09-30 $8.6M 195k 44.09

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Stantec

Mackenzie Financial
Jarislowsky, Fraser
Vanguard Group
Royal Bank of Canada
Bank Of Montreal
Fiera Capital Corporation
Connor, Clark & Lunn Investment Management
Amundi
Norges Bank Investment Management
Vontobel Holding
TD Asset Management
Allianz Asset Management
National Bank Of Canada /fi/
Wellington Management Company
Alberta Investment Management Corporation

View all funds holding Stantec